• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Can't Patch Everything: Personalized Medicine for Cell Therapy in Dilated Cardiomyopathy.

作者信息

Sundin Andrew, Balkan Wayne, Hare Joshua M

机构信息

Interdisciplinary Stem Cell Institute University of Miami Miller School of Medicine Miami FL.

Department of Medicine University of Miami Miller School of Medicine Miami FL.

出版信息

J Am Heart Assoc. 2021 Jul 6;10(13):e021867. doi: 10.1161/JAHA.121.021867. Epub 2021 Jul 2.

DOI:10.1161/JAHA.121.021867
PMID:34212767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8403302/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45bd/8403302/795f62dad2b6/JAH3-10-e021867-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45bd/8403302/795f62dad2b6/JAH3-10-e021867-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45bd/8403302/795f62dad2b6/JAH3-10-e021867-g001.jpg

相似文献

1
Can't Patch Everything: Personalized Medicine for Cell Therapy in Dilated Cardiomyopathy.无法修复一切：扩张型心肌病细胞治疗的个性化医学
J Am Heart Assoc. 2021 Jul 6;10(13):e021867. doi: 10.1161/JAHA.121.021867. Epub 2021 Jul 2.
2
A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy.一项评估选择性冠状动脉内输注骨髓来源祖细胞对非缺血性扩张型心肌病患者潜在影响的试点试验：非缺血性扩张型心肌病患者祖细胞移植与功能再生增强试点试验的1年最终结果
Circ Heart Fail. 2009 Sep;2(5):417-23. doi: 10.1161/CIRCHEARTFAILURE.109.855023. Epub 2009 Jul 29.
3
Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.心脏磁共振成像对比经胸超声心动图对因原发性预防植入式心脏复律除颤器治疗评估而转诊的缺血性和非缺血性扩张型心肌病患者的预后益处。
Circ Cardiovasc Imaging. 2016 Oct;9(10). doi: 10.1161/CIRCIMAGING.115.004956.
4
CRT for Dilated Cardiomyopathy: Time for a Personalized Approach.扩张型心肌病的心脏再同步治疗：是时候采取个性化方法了。
JACC Clin Electrophysiol. 2024 Jul;10(7 Pt 1):1465-1467. doi: 10.1016/j.jacep.2024.05.024.
5
Advances in heart failure therapy in pediatric patients with dilated cardiomyopathy.扩张型心肌病患儿心力衰竭治疗的进展。
Heart Fail Rev. 2018 Jul;23(4):555-562. doi: 10.1007/s10741-018-9692-1.
6
Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.过去 30 多年来，托斯卡纳地区特发性扩张型心肌病患者生存率的提高：基于证据的管理的影响。
Circ Heart Fail. 2013 Sep 1;6(5):913-21. doi: 10.1161/CIRCHEARTFAILURE.112.000120. Epub 2013 Jul 25.
7
Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the Gene.基因突变导致扩张型心肌病的临床表型和预后。
Circ Heart Fail. 2020 Oct;13(10):e006832. doi: 10.1161/CIRCHEARTFAILURE.119.006832. Epub 2020 Sep 23.
8
CD34 Cell Transplantation Improves Right Ventricular Function in Patients with Nonischemic Dilated Cardiomyopathy.CD34 细胞移植改善非缺血性扩张型心肌病患者的右心室功能。
Stem Cells Transl Med. 2018 Feb;7(2):168-172. doi: 10.1002/sctm.17-0197.
9
Feature-Tracking Global Longitudinal Strain Predicts Death in a Multicenter Population of Patients With Ischemic and Nonischemic Dilated Cardiomyopathy Incremental to Ejection Fraction and Late Gadolinium Enhancement.特征追踪整体纵向应变比射血分数和钆延迟增强更能预测缺血性和非缺血性扩张型心肌病患者的死亡：一项多中心研究。
JACC Cardiovasc Imaging. 2018 Oct;11(10):1419-1429. doi: 10.1016/j.jcmg.2017.10.024. Epub 2018 Jan 17.
10
Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.经冠状动脉内 CD34+ 干细胞移植治疗非缺血性扩张型心肌病患者：5 年随访结果。
Circ Res. 2013 Jan 4;112(1):165-73. doi: 10.1161/CIRCRESAHA.112.276519. Epub 2012 Oct 12.

本文引用的文献

1
Clinical Outcomes of Autologous Stem Cell-Patch Implantation for Patients With Heart Failure With Nonischemic Dilated Cardiomyopathy.自体干细胞贴补移植治疗非缺血性扩张型心肌病心力衰竭患者的临床转归。
J Am Heart Assoc. 2021 Jul 6;10(13):e008649. doi: 10.1161/JAHA.117.008649. Epub 2021 Jul 2.
2
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial.一项关于自体间充质基质细胞和 c-kit 阳性心肌细胞单独或联合应用于缺血性心力衰竭患者的 II 期研究：CCTRN CONCERT-HF 试验。
Eur J Heart Fail. 2021 Apr;23(4):661-674. doi: 10.1002/ejhf.2178. Epub 2021 Apr 13.
3
Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.
心脏病与中风统计-2021 更新：美国心脏协会报告。
Circulation. 2021 Feb 23;143(8):e254-e743. doi: 10.1161/CIR.0000000000000950. Epub 2021 Jan 27.
4
Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy.非缺血性扩张型心肌病患者对间充质干细胞注射反应性的遗传决定因素。
EBioMedicine. 2019 Oct;48:377-385. doi: 10.1016/j.ebiom.2019.09.043. Epub 2019 Oct 21.
5
Genetics of dilated cardiomyopathy: practical implications for heart failure management.扩张型心肌病的遗传学：心力衰竭管理的实际意义。
Nat Rev Cardiol. 2020 May;17(5):286-297. doi: 10.1038/s41569-019-0284-0. Epub 2019 Oct 11.
6
Clinical Studies of Cell Therapy in Cardiovascular Medicine: Recent Developments and Future Directions.细胞治疗在心血管医学中的临床研究：最新进展与未来方向。
Circ Res. 2018 Jul 6;123(2):266-287. doi: 10.1161/CIRCRESAHA.118.311217.
7
Concerns on a new therapy for severe heart failure using cell sheets with skeletal muscle or myocardial cells from iPS cells in Japan.对日本使用诱导多能干细胞来源的骨骼肌或心肌细胞制成的细胞片治疗严重心力衰竭的新疗法的担忧。
NPJ Regen Med. 2018 Mar 21;3:7. doi: 10.1038/s41536-018-0047-2. eCollection 2018.
8
Stem Cell Therapy in Patients with Chronic Nonischemic Heart Failure.慢性非缺血性心力衰竭患者的干细胞治疗
Stem Cells Int. 2018 Jan 18;2018:6487812. doi: 10.1155/2018/6487812. eCollection 2018.
9
Histone Modification Is Correlated With Reverse Left Ventricular Remodeling in Nonischemic Dilated Cardiomyopathy.组蛋白修饰与非缺血性扩张型心肌病的左心室逆向重构相关。
Ann Thorac Surg. 2017 Nov;104(5):1531-1539. doi: 10.1016/j.athoracsur.2017.04.046. Epub 2017 Jul 29.
10
Phase I Clinical Trial of Autologous Stem Cell-Sheet Transplantation Therapy for Treating Cardiomyopathy.自体干细胞片移植治疗心肌病的 I 期临床试验。
J Am Heart Assoc. 2017 Apr 5;6(4):e003918. doi: 10.1161/JAHA.116.003918.